Article Text

OP0104 Bone Quality, as Measured by Trabecular Bone Score, in Female Postmenopausal Patients with Systemic Sclerosis and Rheumatoid Arthritis
  1. A. Casabella1,
  2. C. Seriolo1,
  3. G. Botticella1,
  4. L. Molfetta2
  1. 1Osteoporosis, Bone and Joint Disease Research Center, CROPO, Research Laboratory and Academic Unit of Rheumatology, University of Genoa
  2. 2Osteoporosis, Bone and Joint Disease Research Center, CROPO, Osteoporosis, Bone and Joint Research Center, CROPO, Genoa, Italy


Background Patients affected by Systemic Sclerosis (SSc) and Rheumatoid Arthritis (RA) might present an increased risk of low bone mass as a result of multisystemic disorder including treatment, low vitamin D levels and physical inactivity[1]. Trabecular Bone Score (TBS) is an index extracted from the dual-energy X-ray absorptiometry (DXA) that provides an indirect measurement of bone axial microarchitecture and allows to get informations about bone quality[2].

Objectives The aim of this study was to assess bone quality in SSc patients using TBS in comparison with a “high-risk” population with RA.

Methods 74 patients (mean age 65±9 years) affected by SSc, 98 RA patients (mean age 61±8 years) and 60 age-matched healthy controls (mean age 64±11 years) were studied. Bone Mineral Density (BMD, g/cm2) of the lumbar spine (L1-L4) was analyzed using DXA scan (Lunar Prodigy). Lumbar spine TBS was derived for each spine DXA examination blinded to clinical parameters and outcomes using TBS iNsight Medimaps (Lunar Prodigy). TBS value >1.350 is considered normal whereas TBS value <1.200 indicates a degraded bone microarchitecture.

Results Out of 74 enrolled patients with SSc, 56 (76%) presented bone loss; in particular 32 (43%) showed osteoporosis and 24 (32%) osteopenia. In RA patients bone loss was observed in 78 patients (80%); in particular 52 osteoporosis (53%) and 41 (42%) osteopenia. BMD was found significantly lower in SSc and RA patients compared with matched control group (respectively, Lumbar spine: 0.998±0.161 g/cm2 and 0.862±0.194 g/cm2 vs 1.240±0.932 g/cm2; Femoral neck: 0.784±0.212 g/cm2 and 0.668±0.141 g/cm2 vs 0.845±0.164 g/cm2; Ward 0.563±0.173 g/cm2 and 0.486±0.221 g/cm2 vs 0.657±0.106 g/cm2; Trochanter: 0.666 ±0.104 g/cm2 and 0.598±0.231 g/cm2 vs 0.725±0.143 g/cm2; Total hip: 0.827±0.182 g/cm2 and 0.764±0.244 g/cm2 vs 1.033±0.161 g/cm2, all p<0.001). Lumbar spine TBS was found significantly lower in SSc and RA patients compared with matched control group (respectively, 1.032±0.163 and 0.904±0.148 vs 1.361±0.126, both p<0.001). There was no significant difference in mean lumbar spine TBS between patients with SSc and RA (p=0.238).

Conclusions This detailed study shows a decreased BMD and TBS values in SSc and RA patients when compared to healthy controls. In addition TBS, evaluated at the lumbar spine, with lumbar and femoral BMD, could discriminate patients with alterated bone microstructure and could become a new clinical tool in the general diagnosis of osteoporosis in inflammatory rheumatic diseases, such as SSc and RA.

  1. Cutolo M et al. Autoimmun Rev 2011:12;84–7

  2. Roux JP et al. Osteoporosis Int 2013; 24(9):2455–60.

Disclosure of Interest None declared

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.